Parkinson Disease
SCHWARZ PHARMA and UCB, Inc. Announce U.S. Launch of Neupro (Rotigotine Transdermal System) for the Treatment of Early-Stage Parkinson's Disease
Published in Lab Law Weekly, August 3rd, 2007
SCHWARZ PHARMA and UCB, Inc. announced that Neupro(R) (Rotigotine Transdermal System), a new once-daily transdermal dopamine agonist approved for the treatment of the signs and symptoms of early-stage idiopathic Parkinson's disease, is now commercially available in retail pharmacies throughout the United States. Neupro(R) will be co-promoted by SCHWARZ PHARMA and UCB, Inc. These companies have dedicated sales forces that will immediately begin reaching out to physicians who treat Parkinson's disease nationwide.
In conjunction with the U.S. launch, the companies are also kicking off PD-Aware, a public education campaign which aims to raise the profile of Parkinson's...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly
Source: Lab Law Weekly (2007-08-03)
More Articles from Lab Law Weekly
- Aarp
Status: - Boston Scientific Corporation
Boston Scientific Announces Agreement to Settle Product Lawsuits - Cancer
Edward Unveils Details of Plans for Hospital, Cancer Center in Plainfield; New state law positively impacts application - Cancer Vaccines
Novartis delivers strong performance in first half of 2007 (H1 - Report) - Clinical Data, Inc.
Clinical Data Prices 3,000,000 Share Common Stock Offering - Clinical Trial Research
ArQule Announces Exercise of over-Allotment Option - More from this issue of Lab Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
